This compound is a pharmaceutical intermediate used in the synthesis of kinase inhibitors. It features a pyrrolopyrimidine core with a chloro substituent and a trimethylsilylethoxymethyl protecting group.
Portée du contenu: Les informations de cette page concernent l'identification chimique ainsi que les contextes d'approvisionnement industriel, de recherche et de production. Elles ne constituent ni une allégation thérapeutique, ni un avis médical, ni une notice d'utilisation médicamenteuse.
Approvisionnement ou fourniture de ce composé?
Publiez votre inventaire ou une demande d'achat
CAS 941685-26-3
5-[4-[[3-Chloro-4-[(3-fluorophenyl)methoxy]phenyl]amino]-6-quinazolinyl]-2-furancarboxaldehyde
Pharmaceutical intermediate for kinase inhibitors
3-Amino-5-(4-phenoxyphenyl)-1H-pyrazole-4-carbonitrile
Pharmaceutical intermediate for kinase inhibitors
4-Chloro-7-(p-toluenesulfonyl)-7H-pyrrolo[2,3-d]pyrimidine
Pharmaceutical intermediate for kinase inhibitors
6-CHLORO-1H-PYRROLO[2,3-B]PYRIDINE
Pharmaceutical intermediate for kinase inhibitors
Acetic acid, [(phenylthioxomethyl)thio]-
Pharmaceutical intermediate
Sodium 1-benzyl-5-phenylbarbiturate
pharmaceutical intermediate
4-(benzyloxy)-2-methyl-1H-benzo[d]imidazole-6-carboxylic acid
Pharmaceutical intermediate
4-(Benzyloxy)-N,N,2-trimethyl-1-tosyl-1H-benzo[d]imidazole-6-carboxamide
pharmaceutical intermediate
2-[(4-chloropyrrolo[2,3-d]pyrimidin-7-yl)methoxy]ethyl-trimethylsilane
YWBDBLXIRAQZIH-UHFFFAOYSA-N
C[Si](C)(C)CCOCN1C=CC2=C1N=CN=C2Cl
—